Urodoxa 1 mg, 2 mg, 4 mg and 8 mg Tablets
PDF Leaflet Revision Date: 26 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and benign prostatic hyperplasia.
Dosage (summary)
Initial dose 1 mg daily, may increase to 2-4 mg; max 8 mg.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Additive hypotension with PDE-5 inhibitors
- Enhanced hypotensive effects with diuretics
Contraindications
- Hypersensitivity to quinazolines
- History of orthostatic hypotension
- Severe urinary tract obstruction
Common side effects
- Dizziness
- Headache
- Hypotension
- Fatigue
Counselling Points
- Avoid driving if drowsy
- Monitor blood pressure regularly
- Take initial dose at bedtime
Serious warnings
- Risk of first-dose hypotension
- Caution in patients with angina
Important Disclaimer
The Urodoxa 1 mg, 2 mg, 4 mg and 8 mg Tablets professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
